Board of Directors
Founded Cansortium Holdings in 2015 with the mission of redefining excellence in medical cannabis and to provide access and unrivaled care to patients who need it most. Extensive background in real estate development, investment, risk management, and capital raising for companies in highly regulated markets. Born in London and raised in Venezuela, Mr. Hidalgo spent over 20 years as a mortgage banking executive in the United States, most recently as Managing Director at Quontic Bank and then founder of Habitribe, LLC, a national residential redevelopment firm.
Co-founded Cansortium Holdings in 2015 after a successful career in law and real estate development. Previously co-founded Habitribe, LLC, a national residential redevelopment firm, with Mr. Hidalgo. 20 year real estate development career bringing over two million square feet of multi-family housing and commercial properties to the market. Former tax attorney at international law firm Paul, Weiss, Wharton, Rifkind & Garrison LLC, focused on major corporate mergers and acquisitions.
Joined Cansortium Holdings in 2015 and is a former investment banker, law school graduate and a founding partner of a national public affairs firm with extensive experience in healthcare, commercial lending, financing and insurance transactions. Began his career as staff analyst with the Florida House of Representatives Committee on Agriculture, responsible for researching and drafting legislation on issues relating to agriculture and food safety. Previously CEO of a healthcare company and a Board Member or Advisor for multiple privately held healthcare and technology companies.
Currently is the Head of Investments and Strategy for Harris Blitzer Sports & Entertainment (“HBSE”). Prior to this position, Mr. Abrams was the Senior Managing Director at Cerberus European Capital Advisors, LLP, with a 30 year career specializing in lending, distressed assets and specialty finance. Prior to joining Cerberus in 2016, Mr. Abrams was the Managing Partner of the Apollo European Principal Finance Funds franchise which had approximately $5 billion of AUM focused on acquiring distressed debt, real estate, and non-performing loans.
Neal Hochberg is a Senior Managing Director and Vice Chairman of the FTI Consulting segment. For the last 28 years he has focused on accounting, forensic investigations, resolution of complex economic and financial disputes. His career includes service as a forensic and litigation partner at two of the Big 4 accounting firms. Currently, he is serving as the project delegate to the World Economic Forum’s Partnering Against Corruption Initiative and recently completed an engagement as a Compliance consultant in a multi-year deferred prosecution agreement.
Joined Cansortium Holdings in 2015 following a 25-year career advising the financial strategies of institutional and high-net-worth individual investors. In 2001, opened a consulting practice catering to Canadian private equity and venture capital firms culminating in a principal role with a strategic private capital development firm.
John McKimm’s experience spans over 35 years of serving as a director and an officer of many public and private companies, where he provided operations, investment banking, and corporate finance expertise. He possesses a deep knowledge in dealing with emerging and growth companies, having personally identified, negotiated and executed more than 150 individual merger, acquisition and financing transactions.
From 2006 to 2018 he was Associate General Counsel and Senior Vice President of Sun Capital Partners, Inc., a private investment firm that has invested in over 365 companies worldwide with revenues of approximately $50 billion across a broad range of industries and transaction structures. He began his career as a corporate and securities attorney for Morgan, Lewis & Bockius LLP in Philadelphia, PA, where for 6 years he represented both public and private clients in a wide range of M&A activity and SEC reporting. Todd received a Bachelor of Arts degree in History from the University of Florida, and a Juris Doctor degree from the Dickinson School of Law of Pennsylvania State University.
Dr. McCafferty-Fernandez earned her PhD from the University of Miami in the Department of Molecular and Cellular Pharmacology and served in a variety of roles including the Deputy Executive Dean of Research and the acting Executive Director of the Office of Research Compliance for the Miller School of Medicine. She is also certified as an ethics and compliance professional covering expertise in research, healthcare, privacy, and corporate affairs. As the Chief Research Officer and senior research official at Nicklaus Children’s Health System, Dr. McCafferty grew the research and research compliance infrastructures, including concerted efforts in patient and provider reported outcomes studies, genomics and personalized medicine.